Last update 28 Dec 2024

Anti-CD123 CAR-T cell therapy (Hebei Senlang Biotechnology)

Overview

Basic Info

Drug Type
CAR-T
Synonyms
AntiCD123 CART cell therapy Hebei Senlang Biotechnology, AntiIL3RA CART cell therapy
Target
CD123
Action-
Mechanism
CD123 inhibitors(Interleukin-3 receptor subunit alpha inhibitors), Gene transference, T lymphocyte replacements
Therapeutic Areas
NeoplasmsHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Acute Myeloid Leukemia
Originator Organization
Hebei Senlangbio Biotechnology Co., Ltd.Hebei Senlangbio Biotechnology Co., Ltd.
Active Organization-
Inactive Organization
Hebei Senlangbio Biotechnology Co., Ltd.Hebei Senlangbio Biotechnology Co., Ltd.
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Anti-CD123 CAR-T cell therapy (Hebei Senlang Biotechnology)
Login to view more data
100 Translational Medicine associated with Anti-CD123 CAR-T cell therapy (Hebei Senlang Biotechnology)
Login to view more data
100 Patents (Medical) associated with Anti-CD123 CAR-T cell therapy (Hebei Senlang Biotechnology)
Login to view more data
100 Deals associated with Anti-CD123 CAR-T cell therapy (Hebei Senlang Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute Myeloid LeukemiaPhase 1
China
Hebei Senlangbio Biotechnology Co., Ltd.Hebei Senlangbio Biotechnology Co., Ltd.
10 Jan 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free